This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

R1 RCM Beheer

Beheer criteriumcontroles 2/4

De CEO R1 RCM is Lee Rivas, benoemd in Jan2023, heeft een ambtstermijn van 1.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 14.16M, bestaande uit 6.4% salaris en 93.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.026% van de aandelen van het bedrijf, ter waarde € 1.46M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.3 jaar en 6.6 jaar.

Belangrijke informatie

Lee Rivas

Algemeen directeur

US$14.2m

Totale compensatie

Percentage CEO-salaris	6.4%
Dienstverband CEO	1.8yrs
Eigendom CEO	0.03%
Management gemiddelde ambtstermijn	3.3yrs
Gemiddelde ambtstermijn bestuur	6.6yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Lee Rivas's beloning veranderd ten opzichte van R1 RCM's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$61m
Jun 30 2024	n/a	n/a	-US$40m
Mar 31 2024	n/a	n/a	-US$33m
Dec 31 2023	US$14m	US$900k	US$3m
Sep 30 2023	n/a	n/a	-US$35m
Jun 30 2023	n/a	n/a	-US$65m
Mar 31 2023	n/a	n/a	-US$91m
Dec 31 2022	US$4m	US$375k	-US$63m

Compensatie versus markt: De totale vergoeding ($USD 14.16M ) Lee } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 3.59M ).

Compensatie versus inkomsten: De vergoeding van Lee is gestegen terwijl het bedrijf verliesgevend is.

CEO

Lee Rivas (49 yo)

1.8yrs

Tenure

US$14,159,376

Compensatie

Mr. Lee Rivas served as President of R1 RCM Inc. since June 21, 2022 until December 31, 2022. He is Chief Executive Officer and Director at R1 RCM Inc. since January 01, 2023. Mr. Rivas joined R1 RCM Inc....

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Lee Rivas	CEO & Director	1.8yrs	US$14.16m	0.026% € 1.5m
John Sparby	President	1.8yrs	US$3.34m	0.062% € 3.5m
Jennifer Williams	Executive VP	1.8yrs	US$3.20m	0.0014% € 82.1k
Kyle Hicok	Executive VP & Chief Commercial Officer	1.8yrs	US$2.34m	0.0013% € 74.7k
Pamela Spikner	Principal Accounting Officer & Chief Accounting Officer	3.3yrs	geen gegevens	0.0063% € 361.1k
Brian Gambs	EVP & Chief Technology Officer	no data	geen gegevens	geen gegevens
Evan Smith	Senior Vice President of Finance & Investor Relations	1.2yrs	geen gegevens	geen gegevens
Corey Perman	Executive Vice President of Compliance & Risk	8.3yrs	geen gegevens	geen gegevens
Sean Radcliffe	Executive VP	7.8yrs	geen gegevens	geen gegevens
Kate Sanderson	Executive VP & Chief Human Resources Officer	6yrs	geen gegevens	geen gegevens
Logan Johnston	Executive Vice President of Performance Management	7.3yrs	geen gegevens	geen gegevens
David Strickle	Executive Vice President of Integration	6.8yrs	geen gegevens	geen gegevens

3.3yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 6HL0 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Lee Rivas	CEO & Director	1.8yrs	US$14.16m	0.026% € 1.5m
Neal Moszkowski	Independent Director	8.8yrs	geen gegevens	geen gegevens
John Henneman	Lead Independent Director	8.8yrs	US$320.02k	0.017% € 973.8k
Jill Smith	Independent Director	5.6yrs	US$275.00k	0.0095% € 543.1k
Anthony Tersigni	Director	5.3yrs	US$285.02k	0.013% € 725.6k
Anthony Speranzo	Chairman of the Board	8.8yrs	US$400.01k	0.013% € 769.6k
David Dill	Director	3.6yrs	US$285.01k	0.0065% € 368.5k
Agnes Bundy Scanlan	Independent Director	3.3yrs	US$278.77k	0.0041% € 234.5k
Ian Sacks	Independent Director	8.8yrs	geen gegevens	geen gegevens
Joseph Flanagan	Director	8.5yrs	US$207.18k	0.80% € 45.5m
Michael Feiner	Independent Director	7.7yrs	US$265.02k	0.011% € 613.3k
Bradford Armbrester	Independent Director	2.4yrs	US$265.02k	0.0027% € 152.9k

6.6yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 6HL0 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.6 jaar).

This company listing is no longer active

R1 RCM Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

R1 RCM Inc., Annual General Meeting, May 22, 2024

R1 RCM Inc. Appoints Pamela L. Spikner as Principal Accounting Officer

R1 RCM Inc. Appoints Clay Ashdown as Director

R1 RCM Inc. Announces Janie Wade Resigns from its Board of Directors

Senior VP recently sold €452k worth of stock

President recently sold €298k worth of stock

Recent updates

R1 RCM Inc.(NasdaqGM:RCM) dropped from NASDAQ Composite Index

R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P Health Care Services Select Industry Index

Third quarter 2024 earnings released: US$0.047 loss per share (vs US$0.003 profit in 3Q 2023)

R1 RCM Inc. Provides Unaudited Preliminary Financial Guidance for the Fiscal Quarter Ended September 30, 2024

Second quarter 2024 earnings released: US$0.018 loss per share (vs US$0.002 loss in 2Q 2023)

TowerBrook Capital Partners L.P. and Clayton, Dubilier & Rice, LLC agreed to acquire remaining 64% stake in R1 RCM Inc. (NasdaqGS:RCM) from TowerBrook Capital Partners L.P. and others for $6.3 billion.

R1 RCM Inc. to Report Q2, 2024 Results on Aug 07, 2024

R1 RCM Inc. Revises Earnings Guidance for the Year 2024

First quarter 2024 earnings released: US$0.083 loss per share (vs US$0.004 profit in 1Q 2023)

R1 RCM Inc., Annual General Meeting, May 22, 2024

R1 RCM Inc. to Report Q1, 2024 Results on May 08, 2024

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2024

New minor risk - Earnings quality

New Mountain Partners V (AIV-D), L.P. and New Mountain Investments V, L.L.C., managed by New Mountain Capital, L.L.C. submits a non-binding proposal to acquire remaining 67.56906% stake in R1 RCM Inc. (NasdaqGS:RCM) from TowerBrook Investors, Ltd and others for approximately $4 billion.

Full year 2023 earnings released: EPS: US$0.008 (vs US$0.18 loss in FY 2022)

Coliseum Capital Issues an Open Letter to the Board of R1 RCM

R1 RCM Inc. Appoints Pamela L. Spikner as Principal Accounting Officer

R1 RCM Inc. (NasdaqGS:RCM) completed the acquisition of Acclara Solutions, LLC from Providence St. Joseph Health for $680 million.

R1 RCM Inc. to Report Q4, 2023 Results on Feb 27, 2024

R1 RCM Inc. Appoints Clay Ashdown as Director

R1 RCM Inc. (NasdaqGS:RCM) entered into the Purchase Agreement to acquire Acclara Solutions, LLC from Providence St. Joseph Health.

R1 RCM Inc. (NasdaqGS:RCM) entered into the Purchase Agreement to acquire Acclara Solutions, LLC from Providence St. Joseph Health.

R1 RCM Receives Notice Of Filing Delinquency from Nasdaq

R1 RCM Receives Notice Of Filing Delinquency from Nasdaq

R1 RCM Inc. announced delayed 10-Q filing

R1 RCM Inc. Provides Revenue Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.003 (vs US$0.071 loss in 3Q 2022)

R1 RCM Inc. Announces Janie Wade Resigns from its Board of Directors

New minor risk - Share price stability

R1 RCM Inc. to Report Q3, 2023 Results on Nov 02, 2023

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: US$0.001 (vs US$0.069 loss in 2Q 2022)

R1 RCM Inc. Provides Earnings Guidance for the Year of 2023

R1 RCM Inc. to Report Q2, 2023 Results on Aug 02, 2023

Senior VP recently sold €452k worth of stock

President recently sold €298k worth of stock

R1 RCM Inc. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: EPS: US$0.001 (vs US$0.10 in 1Q 2022)

CEO & Director recently bought €937k worth of stock

Full year 2022 earnings released: US$0.16 loss per share (vs US$1.86 loss in FY 2021)

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2023

R1 RCM Inc. to Report Q4, 2022 Results on Feb 16, 2023

R1 RCM Inc. Announces Chief Financial Officer Changes

R1 RCM Inc. Appoints Janie Wade as a Director of the Company, Effective January 1, 2023

R1 RCM Inc. Announces Retirement of Albert Zimmerli from the Board of Directors, Effective January 1, 2023

Third quarter 2022 earnings released: US$0.071 loss per share (vs US$0.061 profit in 3Q 2021)

R1 RCM Inc. Provides Earnings Guidance for the Year 2022

R1 RCM Inc. to Report Q3, 2022 Results on Nov 08, 2022

Key Executive recently sold €996k worth of stock

R1 RCM Inc. Appoints Brian Dean as Director

Independent Director recently sold €266k worth of stock

Second quarter 2022 earnings released: US$0.069 loss per share (vs US$0.069 profit in 2Q 2021)

R1 RCM Inc. Provides Revenue Guidance for the Full Year of 2022

R1 RCM Inc. to Report Q2, 2022 Results on Aug 03, 2022

New Mountain Capital Engages in Discussions with R1 RCM Inc

R1 RCM Inc. Revises Revenue Guidance for the Year 2022

R1 RCM Inc. Announces Committee Changes

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd